Kayne Anderson Rudnick Investment Management Portfolio holdings
AUM
$41.9B
1-Year Return
15.28%
This Quarter Return
+9.14%
1 Year Return
+15.28%
3 Year Return
+74.75%
5 Year Return
+124.58%
10 Year Return
+522.55%
AUM
$43.1B
AUM Growth
+$3.17B
(+7.9%)
Cap. Flow
+$243M
Cap. Flow
% of AUM
0.56%
Top 10 Holdings %
Top 10 Hldgs %
19.67%
Holding
1,006
New
45
Increased
245
Reduced
374
Closed
50
Top Buys
| 1 |
Equifax
EFX
|
+$105M |
| 2 |
BJs Wholesale Club
BJ
|
+$93.9M |
| 3 |
Pool Corp
POOL
|
+$69.1M |
| 4 |
Wabtec
WAB
|
+$65M |
| 5 |
Cooper Companies
COO
|
+$63.9M |
Top Sells
| 1 |
Manhattan Associates
MANH
|
+$210M |
| 2 |
ANSS
Ansys
ANSS
|
+$205M |
| 3 |
BILL Holdings
BILL
|
+$144M |
| 4 |
MarketAxess Holdings
MKTX
|
+$144M |
| 5 |
Emcor
EME
|
+$138M |
Sector Composition
| 1 | Industrials | 32.65% |
| 2 | Technology | 19.32% |
| 3 | Financials | 18.77% |
| 4 | Consumer Discretionary | 10.62% |
| 5 | Healthcare | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
FIVE9
FIVN
$2.04B
| $1.52M | ﹤0.01% |
24,401
+273
| +1% | +$17K |
|
352
iShares MSCI Malaysia ETF
EWM
$242M
| $1.43M | ﹤0.01% |
65,534
-3,776
| -5% | -$82.3K |
|
353
SPDR Gold Trust
GLD
$115B
| $1.4M | ﹤0.01% |
6,828
-866
| -11% | -$178K |
|
354
Equinix
EQIX
$76.3B
| $1.39M | ﹤0.01% |
1,681
+8
| +0.5% | +$6.6K |
|
355
American Homes 4 Rent
AMH
$12.8B
| $1.35M | ﹤0.01% |
36,775
+1,077
| +3% | +$39.6K |
|
356
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$16.3B
| $1.31M | ﹤0.01% |
25,428
+7,704
| +43% | +$397K |
|
357
iShares MSCI Japan ETF
EWJ
$15.7B
| $1.2M | ﹤0.01% |
16,836
-1,104
| -6% | -$78.7K |
|
358
Procore
PCOR
$10.5B
| $1.15M | ﹤0.01% |
14,000
| – | – |
|
359
Vanguard Information Technology ETF
VGT
$101B
| $1.15M | ﹤0.01% |
2,192
| – | – |
|
360
L3Harris
LHX
$50.6B
| $1.12M | ﹤0.01% |
5,278
| – | – |
|
361
Hershey
HSY
$38B
| $1.09M | ﹤0.01% |
5,600
| – | – |
|
362
Vanguard S&P 500 ETF
VOO
$732B
| $1.07M | ﹤0.01% |
2,227
+70
| +3% | +$33.7K |
|
363
Novartis
NVS
$248B
| $1.02M | ﹤0.01% |
10,594
-669
| -6% | -$64.7K |
|
364
Invesco QQQ Trust
QQQ
$369B
| $1.01M | ﹤0.01% |
2,280
+254
| +13% | +$113K |
|
365
iShares Biotechnology ETF
IBB
$5.73B
| $1M | ﹤0.01% |
7,287
-366
| -5% | -$50.2K |
|
366
Vanguard Growth ETF
VUG
$188B
| $992K | ﹤0.01% |
2,882
+47
| +2% | +$16.2K |
|
367
Vulcan Materials
VMC
$38.6B
| $987K | ﹤0.01% |
3,616
-38
| -1% | -$10.4K |
|
368
iShares US Healthcare ETF
IYH
$2.79B
| $950K | ﹤0.01% |
15,328
-1,677
| -10% | -$104K |
|
369
Exxon Mobil
XOM
$472B
| $933K | ﹤0.01% |
8,028
-1,154
| -13% | -$134K |
|
370
EPAM Systems
EPAM
$9.19B
| $932K | ﹤0.01% |
3,376
-8,338
| -71% | -$2.3M |
|
371
iShares Russell Mid-Cap Value ETF
IWS
$14.1B
| $921K | ﹤0.01% |
7,344
-538
| -7% | -$67.5K |
|
372
iShares S&P Mid-Cap 400 Growth ETF
IJK
$9.14B
| $914K | ﹤0.01% |
10,003
| – | – |
|
373
HDFC Bank
HDB
$179B
| $907K | ﹤0.01% |
16,197
-31,158
| -66% | -$1.74M |
|
374
Dover
DOV
$24B
| $886K | ﹤0.01% |
5,000
| – | – |
|
375
Bank of America
BAC
$372B
| $885K | ﹤0.01% |
23,329
+11,396
| +95% | +$432K |
|